XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.0.1
Goodwill and Intangible Assets, Net (Tables)
 9 Months Ended
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of changes in the carrying amount of goodwill
Changes in the carrying amount of goodwill were as follows:
(In millions)U.S. PharmaceuticalPrescription Technology SolutionsMedical-Surgical Solutions
International (1)
Total
Balance, March 31, 2021$3,963 $1,542 $2,453 $1,535 $9,493 
Goodwill acquired— — — 5 5 
Foreign currency translation adjustments, net(21)— — (15)(36)
Balance, December 31, 2021$3,942 $1,542 $2,453 $1,525 $9,462 
(1)    Remaining goodwill for this segment primarily relates to the McKesson Canada reporting unit.
Schedule of information regarding intangible assets
Information regarding intangible assets is as follows:
 December 31, 2021March 31, 2021
(Dollars in millions)Weighted-
Average
Remaining
Amortization
Period
(Years)		Gross
Carrying
Amount		Accumulated
Amortization		Net
Carrying
Amount		Gross
Carrying
Amount		Accumulated
Amortization		Net
Carrying
Amount
Customer relationships12$2,842 $(1,718)$1,124 $3,739 $(2,269)$1,470 
Service agreements91,083 (558)525 1,081 (513)568 
Pharmacy licenses—— — — 497 (244)253 
Trademarks and trade names12816 (371)445 925 (394)531 
Technology2128 (113)15 150 (122)28 
Other8192 (171)21 254 (226)28 
Total $5,061 $(2,931)$2,130 
(1)
$6,646 $(3,768)$2,878 
(1)Excludes net intangible assets of approximately $452 million related to the European divestiture activities discussed in more detail in Financial Note 2, “Held for Sale.” This amount was included under the caption “Assets held for sale” in the Condensed Consolidated Balance Sheet as of December 31, 2021. Amortization of these assets ceased upon classification as Assets held for sale in the second and third quarters of 2022.